Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 38.98% Profit Signal Success

August 08, 2023
ELI LILLY AND COMPANY stock has successfully reached the forecast price target set by QuantWave, resulting in a profit of 38.98%. The forecast signal was initiated on April 26, 2023, with a price of 369.17 $. The predicted direction was long, and on August 8, 2023, the stock price reached 513.09 $. This achievement highlights the accuracy and reliability of QuantWave's analytics in predicting stock movements.

Several factors may have contributed to ELI LILLY AND COMPANY's stock reaching the forecast price target. Positive developments within the pharmaceutical industry, such as successful drug trials or regulatory approvals, could have boosted investor confidence in the company's future prospects. Additionally, macroeconomic trends and market sentiment towards healthcare stocks may have played a role in driving the stock price higher.

QuantWave's success in accurately forecasting ELI LILLY AND COMPANY's stock movement demonstrates the platform's effectiveness in providing valuable insights for investors. By leveraging QuantWave's automated forecasting capabilities, users can access predictions for a wide range of stocks and potentially capitalize on profitable opportunities. For investors interested in enhancing their investment strategy, exploring QuantSchool's educational resources can provide a comprehensive framework for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


PFEMarch 11, 2024PFIZER INC. Hits Price Target Forecast with 8.78% Profit Margin  ~1 min.

On March 5, 2024, QuantWave's automated forecasting platform issued a long signal for PFIZER INC. with a price target of $25.75. The stock was trading at $23....


PFEDecember 14, 2022PFIZER INC. Hits Price Target Forecast with 9.65% Profit: A Success Story for QuantWave  ~1 min.

In a significant milestone for QuantWave, the automated forecasting platform successfully predicted a long signal for PFIZER INC. on August 12, 2022, when the stock was trading at 43.24 $....


REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....


NVOJuly 31, 2025NOVO NORDISK A/S Stock Hits Price Target Forecast with 21.43% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the short direction for NOVO NORDISK A/S stock on April 22, 2025, when the price was at 59.91 $....


PFEJuly 30, 2024Pfizer Inc. Stock Hits Forecast Price Target with 17.12% Profit Margin  ~1 min.

On March 26, 2024, QuantWave forecasted a long signal for Pfizer Inc. stock when it was trading at $25.04....